[go: up one dir, main page]

WO2008093772A1 - 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 - Google Patents

経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 Download PDF

Info

Publication number
WO2008093772A1
WO2008093772A1 PCT/JP2008/051499 JP2008051499W WO2008093772A1 WO 2008093772 A1 WO2008093772 A1 WO 2008093772A1 JP 2008051499 W JP2008051499 W JP 2008051499W WO 2008093772 A1 WO2008093772 A1 WO 2008093772A1
Authority
WO
WIPO (PCT)
Prior art keywords
adjuvant
transdermal
transmucosal administration
same
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/051499
Other languages
English (en)
French (fr)
Inventor
Tetsuji Kuwahara
Seiji Tokumoto
Toshiyuki Matsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to EP08710659.7A priority Critical patent/EP2123296B1/en
Priority to US12/524,748 priority patent/US20100047327A1/en
Priority to JP2008556170A priority patent/JP5275047B2/ja
Publication of WO2008093772A1 publication Critical patent/WO2008093772A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

　本発明の課題は、経皮または経粘膜投与により皮膚刺激等を誘発することなく安全に投与可能であり、抗原の免疫原性を効率よく増強するための低分子アジュバントを提供することであり、前記課題は、脂肪族アルコール類、遊離脂肪酸類および脂肪酸誘導体からなる群から選択される少なくとも１種を含み、下記式で示されるものを含まない免疫賦活用アジュバントにより解決される。 　（式中、Ｒ３およびＲ４は結合して環式環を形成してもよく、また、Ｒ１およびＲ２は独立して１～１６個の炭素原子を含むアルキル側鎖である）。
PCT/JP2008/051499 2007-01-31 2008-01-31 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 Ceased WO2008093772A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08710659.7A EP2123296B1 (en) 2007-01-31 2008-01-31 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
US12/524,748 US20100047327A1 (en) 2007-01-31 2008-01-31 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
JP2008556170A JP5275047B2 (ja) 2007-01-31 2008-01-31 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-022061 2007-01-31
JP2007022061 2007-01-31

Publications (1)

Publication Number Publication Date
WO2008093772A1 true WO2008093772A1 (ja) 2008-08-07

Family

ID=39674078

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/051499 Ceased WO2008093772A1 (ja) 2007-01-31 2008-01-31 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤

Country Status (4)

Country Link
US (1) US20100047327A1 (ja)
EP (1) EP2123296B1 (ja)
JP (1) JP5275047B2 (ja)
WO (1) WO2008093772A1 (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012115222A1 (ja) 2011-02-25 2012-08-30 久光製薬株式会社 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
JP2014169276A (ja) * 2013-02-05 2014-09-18 Nitto Denko Corp 経皮投与用ｗｔ１ペプチド癌ワクチン組成物
JP2014169279A (ja) * 2013-02-05 2014-09-18 Nitto Denko Corp 経皮投与用ｗｔ１ペプチド癌ワクチンテープ剤
WO2015064710A1 (ja) 2013-10-31 2015-05-07 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット
JP2017537690A (ja) * 2014-11-12 2017-12-21 ミューファーマ ピーティーワイ リミテッド 非侵襲性の薬剤塗布具
JP2021028009A (ja) * 2015-03-24 2021-02-25 フィーリグリーンＦｅｅｌｉｇｒｅｅｎ イオン導入用接着性高分子マトリックス及び同マトリックスを有するイオン導入装置
JP2023546646A (ja) * 2020-08-28 2023-11-07 エルテーエス ローマン テラピー－ジステーメ アーゲー 粘膜の穿孔
US12029873B2 (en) 2014-05-06 2024-07-09 Mupharma Pty Ltd Non-invasive agent applicator

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013051568A1 (ja) 2011-10-06 2013-04-11 久光製薬株式会社 アプリケータ
JP6512568B2 (ja) * 2013-02-05 2019-05-15 日東電工株式会社 経皮投与用ｗｔ１ペプチド癌ワクチン組成物
HK1243330A1 (zh) * 2014-12-22 2018-07-13 久光制药株式会社 泥罨剂
IL308552A (en) * 2021-05-21 2024-01-01 Veradermics Incorporated Microneedle patch for administration of immunostimulating drugs

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09508614A (ja) * 1993-02-15 1997-09-02 リュフヤトルン・エイチ・エフ 哺乳動物に対する抗原類および／またはワクチン類の粘膜を介した局所投与のための医薬調製物
JPH10500662A (ja) * 1994-02-24 1998-01-20 マイクロパック インコーポレイテッド 免疫アジュバントとして少ラメラ脂質小胞を含むワクチン
JP2001509491A (ja) * 1997-07-09 2001-07-24 リュフヤトルン・エイチエフ，ジ・アイスランディック・バイオ・ファーマシューティカル・グループ アジュバントとしてモノグリセリドまたはジグリセリドを含む抗原送達系
JP2001517233A (ja) 1997-03-21 2001-10-02 カイロン コーポレイション 非経口アジュバントとしての細菌性ａｄｐ−リボシル化毒素の無毒化された変異体
WO2002017961A1 (en) * 2000-08-31 2002-03-07 The Kitasato Institute Vaccine preparation containing fatty acid as component
JP2002512186A (ja) 1998-04-20 2002-04-23 トレイ パインズ インスティチュート フォー モレキュラー スタディーズ ランゲルハンス細胞遊走を誘導する局所的免疫刺激
JP2002535100A (ja) 1999-01-28 2002-10-22 サイト パルス サイエンシズ、インコーポレイテッド 細胞内への巨大分子の送達
JP2003509473A (ja) * 1999-09-24 2003-03-11 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム ワクチン
JP2004504120A (ja) 2000-07-21 2004-02-12 グラクソスミスクライン　バイオロジカルズ　ソシエテ　アノニム ワクチン
JP2004083520A (ja) * 2002-08-28 2004-03-18 Hisamitsu Pharmaceut Co Inc 貼付剤
JP2004510747A (ja) * 2000-10-02 2004-04-08 グラクソスミスクライン　バイオロジカルズ　ソシエテ　アノニム 分割エンベロープウイルス調製物
JP2004526757A (ja) 2001-04-11 2004-09-02 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 抗原担体として有用な抗炎症性脂肪族アルコールと脂肪酸エステル
JP2004528900A (ja) 2001-04-20 2004-09-24 アルザ・コーポレーシヨン 有益な作用物質を含有するコーティングを有する微小突起アレイ
JP2004529906A (ja) 2001-03-19 2004-09-30 イオマイ コーポレイシヨン 経皮的免疫賦活
JP2004538048A (ja) 2001-04-20 2004-12-24 アルザ・コーポレーシヨン 微小突起アレイ免疫感作貼付剤および方法
WO2005016440A1 (en) 2003-08-04 2005-02-24 Alza Corporation Method and device for enhancing transdermal agent flux
WO2007015441A1 (ja) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよび製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
US7988991B2 (en) * 2001-03-07 2011-08-02 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US20040109869A1 (en) * 2001-03-19 2004-06-10 Iomai Corporation Transcutaneous immunostimulation
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
AU2003205979A1 (en) * 2002-02-25 2003-09-09 Lyfjathroun Hf, Biopharmaceutical Research An immunological adjuvant
JP4295467B2 (ja) * 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2005042054A2 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09508614A (ja) * 1993-02-15 1997-09-02 リュフヤトルン・エイチ・エフ 哺乳動物に対する抗原類および／またはワクチン類の粘膜を介した局所投与のための医薬調製物
JPH10500662A (ja) * 1994-02-24 1998-01-20 マイクロパック インコーポレイテッド 免疫アジュバントとして少ラメラ脂質小胞を含むワクチン
JP2001517233A (ja) 1997-03-21 2001-10-02 カイロン コーポレイション 非経口アジュバントとしての細菌性ａｄｐ−リボシル化毒素の無毒化された変異体
JP2001509491A (ja) * 1997-07-09 2001-07-24 リュフヤトルン・エイチエフ，ジ・アイスランディック・バイオ・ファーマシューティカル・グループ アジュバントとしてモノグリセリドまたはジグリセリドを含む抗原送達系
JP2002512186A (ja) 1998-04-20 2002-04-23 トレイ パインズ インスティチュート フォー モレキュラー スタディーズ ランゲルハンス細胞遊走を誘導する局所的免疫刺激
JP2002535100A (ja) 1999-01-28 2002-10-22 サイト パルス サイエンシズ、インコーポレイテッド 細胞内への巨大分子の送達
JP2003509473A (ja) * 1999-09-24 2003-03-11 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム ワクチン
JP2004504120A (ja) 2000-07-21 2004-02-12 グラクソスミスクライン　バイオロジカルズ　ソシエテ　アノニム ワクチン
WO2002017961A1 (en) * 2000-08-31 2002-03-07 The Kitasato Institute Vaccine preparation containing fatty acid as component
JP2004510747A (ja) * 2000-10-02 2004-04-08 グラクソスミスクライン　バイオロジカルズ　ソシエテ　アノニム 分割エンベロープウイルス調製物
JP2004529906A (ja) 2001-03-19 2004-09-30 イオマイ コーポレイシヨン 経皮的免疫賦活
JP2004526757A (ja) 2001-04-11 2004-09-02 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 抗原担体として有用な抗炎症性脂肪族アルコールと脂肪酸エステル
JP2004528900A (ja) 2001-04-20 2004-09-24 アルザ・コーポレーシヨン 有益な作用物質を含有するコーティングを有する微小突起アレイ
JP2004538048A (ja) 2001-04-20 2004-12-24 アルザ・コーポレーシヨン 微小突起アレイ免疫感作貼付剤および方法
JP2004083520A (ja) * 2002-08-28 2004-03-18 Hisamitsu Pharmaceut Co Inc 貼付剤
WO2005016440A1 (en) 2003-08-04 2005-02-24 Alza Corporation Method and device for enhancing transdermal agent flux
WO2007015441A1 (ja) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよび製剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Pharmaceutical Excipients Directory", 2000, JAPAN PHARMACEUTICAL EXCIPIENTS COUNCIL

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5876468B2 (ja) * 2011-02-25 2016-03-02 久光製薬株式会社 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
WO2012115222A1 (ja) 2011-02-25 2012-08-30 久光製薬株式会社 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
US10071051B2 (en) 2013-02-05 2018-09-11 Nitto Denko Corporation WT1 peptide cancer vaccine composition for transdermal administration
JP2014169279A (ja) * 2013-02-05 2014-09-18 Nitto Denko Corp 経皮投与用ｗｔ１ペプチド癌ワクチンテープ剤
JP2014169276A (ja) * 2013-02-05 2014-09-18 Nitto Denko Corp 経皮投与用ｗｔ１ペプチド癌ワクチン組成物
US10195258B2 (en) 2013-02-05 2019-02-05 Nitto Denko Corporation Tape preparation of WT1 peptide cancer vaccine for transdermal administration
JPWO2015064710A1 (ja) * 2013-10-31 2017-03-09 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット
WO2015064710A1 (ja) 2013-10-31 2015-05-07 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット
US9993549B2 (en) 2013-10-31 2018-06-12 Hisamitsu Pharmaceutical Co., Inc. Adjuvant composition, adjuvant preparation containing same, and kit
US12029873B2 (en) 2014-05-06 2024-07-09 Mupharma Pty Ltd Non-invasive agent applicator
JP2017537690A (ja) * 2014-11-12 2017-12-21 ミューファーマ ピーティーワイ リミテッド 非侵襲性の薬剤塗布具
JP7035141B2 (ja) 2014-11-12 2022-03-14 ミューファーマ ピーティーワイ リミテッド 非侵襲性の薬剤塗布具
JP2020195881A (ja) * 2014-11-12 2020-12-10 ミューファーマ ピーティーワイ リミテッド 非侵襲性の薬剤塗布具
US12115333B2 (en) 2014-11-12 2024-10-15 Mupharma Pty Ltd Non-invasive agent applicator
US12521540B2 (en) 2014-11-12 2026-01-13 Mupharma Pty Ltd Non-invasive agent applicator
JP2021028009A (ja) * 2015-03-24 2021-02-25 フィーリグリーンＦｅｅｌｉｇｒｅｅｎ イオン導入用接着性高分子マトリックス及び同マトリックスを有するイオン導入装置
JP2023546646A (ja) * 2020-08-28 2023-11-07 エルテーエス ローマン テラピー－ジステーメ アーゲー 粘膜の穿孔
JP7713006B2 (ja) 2020-08-28 2025-07-24 エルテーエス ローマン テラピー－ジステーメ アーゲー 粘膜の穿孔

Also Published As

Publication number Publication date
EP2123296A4 (en) 2014-03-26
EP2123296A1 (en) 2009-11-25
JPWO2008093772A1 (ja) 2010-05-20
US20100047327A1 (en) 2010-02-25
EP2123296B1 (en) 2019-05-22
JP5275047B2 (ja) 2013-08-28

Similar Documents

Publication Publication Date Title
WO2008093772A1 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
WO2008014979A3 (en) NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
CY1110140T1 (el) Εμβολιασμος με μηνιγγοκοκκικο συζευγμα
ES2253423T3 (es) Formulacion de un ester de testosterona para uso humano.
NO20013367L (no) Colchinolderivater som vaskulorskadende midler
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
EA200501819A1 (ru) Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке
NZ581589A (en) Solubilized sterile injectable formulation of docetaxel without Tween 80
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
EP2272531A3 (en) Integration of meningococcal conjugate vaccination
WO2006029081A3 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
RU2006116567A (ru) Лекарственный препарат и пищевой продукт или напиток для улучшения гипергликемического состояния
NO20045587L (no) Liposom vaksineformulering for finne-fisk
RU2002125463A (ru) Полипептидное соединение, способы его получения, фармацевтическая композиция и способ профилактики или лечения грибковых заболеваний
WO2003105822A8 (en) Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
IL148739A0 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
WO2005016246A3 (en) Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
WO2006071564A3 (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
MX2007002531A (es) Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
NO20024574L (no) Anvendelse av CDP-kolin for behandling av alkoholabstinens
WO2008144355A3 (en) Stable, self-microemulsifying fenofibrate compositions

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08710659

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008556170

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12524748

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2008710659

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE